分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis

Xie Lin, Huang Weibo, Fang Zhenhua, Ding Fan, Zou Fei, Ma Xiaosheng, Tao Jie, Guo Jingkang, Xia Xinlei, Wang Hongli, Yu Zuochong, Lu Feizhou, Jiang Jianyuan

Journal:Cell Death & Disease

IF:5.96

DOI:10.1038/s41419-019-1978-2

PMID:31582722

Published:2019-10-03

research field:分子生物学再生医学骨科

Abstract

The molecular mechanism of intervertebral disc degeneration (IVDD) remains unclear. This study aimed to investigate the role of circular RNAs (circRNAs) in the pathogenesis of IVDD. We sued nucleus pulposus (NP) tissues of patients, tert-butyl hydroperoxide (TBHP) stimulated NP cells (NPCs), and IVDD rat model to explore the interaction between circ ERCC2 and miR-182-5p/SIRT1 axis. The results showed that downregulation of circ ERCC2 increased the level of miR-182-5p and decreased the level of SIRT1 in degenerative NP tissues in vivo as well as in TBHP-stimulated NPCs in vitro. Treatment of SIRT1-si activated apoptosis and inhibited mitophagy. Moreover, miR-182-5p-si could regulate the mitophagy and the apoptosis of NPCs by targeting SIRT1. The effects of circ ERCC2 on NPCs and IVDD rat model were mediated by miR-182-5p/SIRT1 axis. In conclusion, this study provides the first evidence that circ ERCC2 could ameliorate IVDD through miR-182-5p/SIRT1 axis by activating mitophagy and inhibiting apoptosis, and suggests that circ ERCC2 is a potentially effective therapeutic target for IVDD.

本文使用的Yeasen产品

购物车
客服
转染试用